国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (16): 2688-2692.DOI: 10.3760/cma.j.cn441417-20241127-16010

• 论著 • 上一篇    下一篇

益气止鼽汤联合丙酸氟替卡松鼻喷雾剂治疗肺虚感寒型变应性鼻炎的临床疗效

薛翔1  康陆佼2  韦俊荣3   

  1. 1陕西省中医医院中医耳鼻喉科,西安 710000;2陕西省中医医院中医内科,西安 710000;3西安交通大学第二附属医院耳鼻咽喉头颈外科病院,西安 710004

  • 收稿日期:2024-11-27 出版日期:2025-08-15 发布日期:2025-08-28
  • 通讯作者: 康陆佼,Email:13260160717@163.com
  • 基金资助:

    国家自然科学基金(81271057)

Clinical efficacy of Yiqi Zhiqiu Decoction combined with fluticasone propionate nasal spray in treatment of patients with cold-induced allergic rhinitis of lung qi deficiency type

Xue Xiang1, Kang Lujiao2, Wei Junrong3   

  1. 1 Department of Otolaryngology, Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an 710000, China; 2 Department of Chinese Internal Medicine, Shaanxi Provincial Hospital of Traditional Chinese Medicine, Xi'an 710000, China; 3 Department of Otolaryngology, Head, and Neck Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China

  • Received:2024-11-27 Online:2025-08-15 Published:2025-08-28
  • Contact: Kang Lujiao, Email: 13260160717@163.com
  • Supported by:

    National Natural Science Foundation (81271057)

摘要:

目的 探讨益气止鼽汤联合丙酸氟替卡松鼻喷雾剂治疗肺虚感寒型变应性鼻炎的临床疗效。方法 本研究为随机对照试验,纳入2022年4月至2024年4月陕西省中医医院159例肺虚感寒型变应性鼻炎患者,根据随机数字表法分为治疗组与对照组。对照组79例,男41例,女38例,年龄(55.2±6.7)岁,体重指数(BMI)为(23.5±3.1)kg/m²;治疗组80例,男39例,女41例,年龄(54.6±6.5)岁,BMI为(23.8±3.2)kg/m²。对照组使用丙酸氟替卡松鼻喷雾剂,治疗组采用益气止鼽汤联合丙酸氟替卡松鼻喷雾剂治疗;治疗周期为4周。主要观察指标包括疗效、中医证候评分、鼻结膜炎生活质量、炎症因子水平、体液免疫水平及不良反应。统计学方法采用t检验、χ2检验。结果 治疗组的总有效率为96.25%(77/80),高于对照组的78.48%(62/79),差异有统计学意义(P<0.05)。治疗后两组中医证候指标均低于治疗前(均P<0.05),且治疗组改善更为显著[鼻塞:(0.58±0.13)分比(1.31±0.18)分,咳嗽:(0.47±0.09)分比(1.46±0.33)分,流涕:(0.62±0.21)分比(1.76±0.41)分,喷嚏:(0.48±0.13)分比(1.99±0.37)分,咳痰:(0.53±0.11)分比(1.27±0.22)分比,气短乏力:(0.44±0.08)分比(1.43±0.28)分,均P<0.05]。治疗后两组鼻部症状、非鼻部症状、眼部症状、日常生活得分与炎症因子[白细胞介素(IL)-6、IL-12、γ-干扰素]、体液免疫水平[免疫球蛋白(Ig)A、IgG、IgE]均低于治疗前,且治疗组低于对照组(均P<0.05)。结论 益气止鼽汤联合丙酸氟替卡松鼻喷雾剂治疗肺虚感寒型变应性鼻炎能显著改善患者的临床症状,提高治疗效果,值得临床推广应用。

关键词:

变应性鼻炎, 益气止鼽汤, 丙酸氟替卡松鼻喷雾剂, 肺虚感寒型, 临床疗效

Abstract:

Objective To investigate the clinical efficacy of Yiqi Zhiqiu Decoction combined with fluticasone propionate nasal spray for patients with cold-induced allergic rhinitis of lung qi deficiency type. Methods One hundred and fifty-nine patients with cold-induced allergic rhinitis of lung qi deficiency type treated at Shaanxi Provincial Hospital of Traditional Chinese Medicine from April 2022 to April 2024 were selected for the randomized controlled trial, and were divided into a control group (79 cases) and a treatment group (80 cases) by the random number table method. There were 41 males and 38 females in the control group; they were (55.2±6.7) years old; their body mass index (BMI) was (23.5±3.1) kg/m². There were 39 males and 41 females in the treatment group; they were (54.6±6.5) years old; their BMI was (23.8±3.2) kg/m². The control group took fluticasone propionate nasal spray, and the treatment group Yiqi Zhizhou Decoction combined with the nasal spray, for 4 weeks. The main observation indicators included treatment efficacy, traditional Chinese medicine syndrome scores, quality of life, inflammatory factors, immune levels, and adverse reactions. t and χ2 tests were taken as the statistical methods. Results The total effective rate in the treatment group was higher than that in the control group [96.25% (77/80) vs. 78.48% (62/79)], with a statistical difference (P<0.05). After the treatment, the scores of nasal congestion, cough, runny nose, sneezing, sputum, and short breath and fatigue were lower than those before the treatment group in both groups (all P<0.05), and the scores in the treatment group were better than those in the control group (0.58±0.13 vs. 1.31±0.18, 0.47±0.09 vs. 1.46±0.33, 0.62±0.09 vs. 1.76±0.41, 0.48±0.13 vs. 1.99±0.37, 0.53±0.11 vs. 1.27±0.22, and 0.44±0.08 vs. 1.43±0.28; all P<0.05). After the treatment, the scores of nasal, non-nasal, and ocular symptoms and daily activities, the levels of inflammatory factors [interleukin (IL) -6, IL-12, and interferon-γ], and immune levels [immunoglobulin (Ig) A, IgG, and IgE] were lower than those before the treatment in both groups, and those in the treatment group were lower than those in the control group (all P<0.05). Conclusion Yiqi Zhiqiu Decoction combined with fluticasone propionate nasal spray for patients with cold-induced allergic rhinitis of lung qi deficiency type can improve their clinical symptoms and the treatment efficacy, so it is worth being clinically generalized.

Key words:

Allergic Rhinitis, Yiqi Zhiqiu , Decoction, Fluticasone propionate nasal spray, Lung qi deficiency type, Clinical efficacy